Patient-Reported Symptoms and Discontinuation of Adjuvant Aromatase Inhibitor Therapy

BACKGROUND: Aromatase inhibitor (AI) therapy results in substantial survival benefits in hormone receptor-positive breast cancer. Poor adherence and discontinuation rates of AI therapy are high, primarily due to treatment-related toxicities such as musculoskeletal pain. While pain-related symptoms m...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kidwell, Kelley M., Harte, Steven E., Hayes, Daniel F., Storniolo, Anna Maria, Carpenter, Janet, Flockhart, David A., Stearns, Vered, Clauw, Daniel J., Williams, David A., Henry, N. Lynn
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126845/
https://ncbi.nlm.nih.gov/pubmed/24802413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28756
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky